The new generation will accept modern vaccine against the US Agency Covid
FDA, United States Food and Remedies Regulatory Agency, approved Modern new generation vaccine Against (mrna.o) Covid-19 To all the people 65 or moreAccording to a statement released by the company on Saturday (31).
This is the first approval of this type since the regulatory organ needs more harsh the requirements. The vaccine was also approved People between the ages of 12 and 64 with at least one or more pre -risk factorsAccording to the statement, as defined as the disease control and prevention centers (CDC).
The company said it hoped to be a vaccine called vaccine MNEXSPIKEAvailable for season Respiratory viruses In 2025-2026.
“Our third product, MNEXSpike’s FDA approval, adds a new and important tool to help protect people with high risk of developing serious forms Covid-19“Modern CEO Stephen Bank said in the statement.
Control for approval of vaccines
The Department of Health and Human Services of the United States Robert F. Kennedy Junior LeadershipThe vaccine is known for its skepticism, which exacerbates control of immunity.
The FDA has announced on May 20 that drug manufacturers need to test their reinforcement doses against Covid, compared to integrity in healthy adults under the age of 65, under 65 years of approval, Effectively limit the use of the elderly And those who are at risk of serious illness.
Modern vaccine can be stored in refrigerators instead of freezers, which provides Long time and facilitates distributionSupply chain problems in developing countries in particular make vaccinations difficult.
Disease Control and Prevention Centers (CDC), Kennedy also monitored, said that Kovid vaccines last Thursday (29) A choice for healthy children When parents and doctors accept their need, the agency returns to the Kennedy announcement a few days before removing the agency vaccinations from their immunity calendar.
According to analysts, the CDC’s statement will somewhat reduce the anxiety of investors, as it is usually the construction of the elderly and those who are in danger of seeking vaccines.
FDA representatives mentioned From 100 million to 200 million Americans still eligible for annual vaccines.
The demand for modern bets on its new messenger RNA vaccines and its original vaccine will be reduced against the adhesion of the vaccine against the vaccine against Kovid, Spikewax and vaccine. Breathing (Vsr).
MNEXSpike’s approval depends on the advanced phase test data, which shows that it is not under the influence of vaccination compared to Spikewax in 12 years of age or older.
The vaccine also performed A superior efficiency The study compared to spikewax in adults 18 or older.
Kennedy has begun a large reconstruction in the United States health departments, with President Donald Trump’s goal to dramatically cut federal government expenses. It has intensified concerns about Possible disruptions in treatments and vaccination control analysis.
The external panel of CDC vaccine experts discussed reinforcement doses recommendation in April, for the next immunity campaign only for the population of serious Covid -19.
The FDA’s Covid Vaccine approved Novavax.
Conditions that have additional risk vary from diabetes and heart problems to behaviors such as physical passive and drug abuse, according to CDC.
Modern vaccines, as well as camirletty Phyizar-biontecare dependent on MRNA. The Novavax depends on vaccine protein and takes longer to preparation.
Modernly withdrawn, which is a approval request for its candidate against influenza and Kovids to look forward to effective data from the advanced phase of its flu vaccine.
